T1	Participants 77 144	monoclonal antibody purified plasma-derived factor VIII concentrate
T2	Participants 0 40	B-domain deleted recombinant factor VIII
T3	Participants 215 280	B-domain of recombinant blood coagulation factor VIII (BDDrFVIII)
T4	Participants 385 404	BDDrFVIII (ReFacto)
T5	Participants 587 607	pharmacokinetic (PK)
T6	Participants 626 648	BDDrFVIII formulations
T7	Participants 800 860	FVIII preparation (Hemofil M) in patients with haemophilia A
T8	Participants 1002 1020	FVIII preparations
T9	Participants 1184 1186	PK
T10	Participants 1605 1626	BDDrFVIII formulation
T11	Participants 1647 1656	Hemofil M
T12	Participants 1495 1508	Cmax and AUCs
